(Total Views: 491)
Posted On: 06/27/2022 3:56:32 PM
Post# of 154119
The lost revenue from impending patent cliff’s is huge and not to be ignored. If it were me I would grab the cheese before someone moves it!
“Depending on the company, on paper, the losses represent from 14% to 79% of their revenues,” Maria Whitman, global head of ZS Associates’ pharmaceutical and biotech practice, told BioSpace. “That’s $6 to $38 billion that any one company will lose in revenues. Another way to think about it is, five of today’s top 10 pharmas (by income) will have more than 50% of their revenues at risk.”
https://www.biospace.com/article/looming-pate...-of-truth/
“Depending on the company, on paper, the losses represent from 14% to 79% of their revenues,” Maria Whitman, global head of ZS Associates’ pharmaceutical and biotech practice, told BioSpace. “That’s $6 to $38 billion that any one company will lose in revenues. Another way to think about it is, five of today’s top 10 pharmas (by income) will have more than 50% of their revenues at risk.”
https://www.biospace.com/article/looming-pate...-of-truth/
(3)
(0)
